Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Contemporary clinical risk stratification schemata for predicting stroke and thromboembolism (TE) in patients with atrial fibrillation (AF) are largely derived from risk factors identified from trial cohorts. Thus, many potential risk factors have not been included. METHODS: We refined the 2006 Birmingham/National Institute for Health and Clinical Excellence (NICE) stroke risk stratification schema into a risk factor-based approach by reclassifying and/or incorporating additional new risk factors where relevant. This schema was then compared with existing stroke risk stratification schema in a real-world cohort of patients with AF (n = 1,084) from the Euro Heart Survey for AF. RESULTS: Risk categorization differed widely between the different schemes compared. Patients classified as high risk ranged from 10.2% with the Framingham schema to 75.7% with the Birmingham 2009 schema. The classic CHADS(2) (Congestive heart failure, Hypertension, Age > 75, Diabetes, prior Stroke/transient ischemic attack) schema categorized the largest proportion (61.9%) into the intermediate-risk strata, whereas the Birmingham 2009 schema classified 15.1% into this category. The Birmingham 2009 schema classified only 9.2% as low risk, whereas the Framingham scheme categorized 48.3% as low risk. Calculated C-statistics suggested modest predictive value of all schema for TE. The Birmingham 2009 schema fared marginally better (C-statistic, 0.606) than CHADS(2). However, those classified as low risk by the Birmingham 2009 and NICE schema were truly low risk with no TE events recorded, whereas TE events occurred in 1.4% of low-risk CHADS(2) subjects. When expressed as a scoring system, the Birmingham 2009 schema (CHA(2)DS(2)-VASc acronym) showed an increase in TE rate with increasing scores (P value for trend = .003). CONCLUSIONS: Our novel, simple stroke risk stratification schema, based on a risk factor approach, provides some improvement in predictive value for TE over the CHADS(2) schema, with low event rates in low-risk subjects and the classification of only a small proportion of subjects into the intermediate-risk category. This schema could improve our approach to stroke risk stratification in patients with AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, diabetes may not be a significant risk factor for stroke in the elderly.620”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [620]
Experimental — accuracy not yet measuredIn the citing paper
“while patients with stroke risk factors (i.e.CHA 2 DS 2 -VASc score of 1 or more for men, and 2 or more for women) are likely to benefit from OAC.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [368]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Mant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
Self-citationBelch, J., MacCuish, A., Campbell, I., Cobbe, S., Taylor, R., Prescott, R., Lee, R., Bancroft, J., MacEwan, S., Shepherd, J., et al. (2008) · BMJ · doi:10.1136/bmj.a1840 · Cited by 977
Connolly, S. J., Pogue, J., Eikelboom, J., Flaker, G., Commerford, P., Franzosi, M. G., Healey, J. S., & Yusuf, S. (2008) · Circulation · doi:10.1161/circulationaha.107.750000 · Cited by 870
Wang, T. J., Massaro, J. M., Levy, D., Vasan, R. S., Wolf, P. A., D'Agostino, R. B., Larson, M. G., Kannel, W. B., & Benjamin, E. J. (2003) · JAMA · doi:10.1001/jama.290.8.1049 · Cited by 780
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., & Manning, W. J. (2008) · Chest · doi:10.1378/chest.08-0678 · Cited by 751
Self-citationGage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation · doi:10.1161/01.cir.0000145172.55640.93 · Cited by 749
Cited by
Items 201–300 of 1,020
2024 Clinical practice guidelines for Chronic heart failure
Galyavich, A. S., Tereshchenko, S. N., Uskach, T. M., Ageev, F. T., Aronov, D. M., Arutyunov, G. P., Begrambekova, Y. L., Belenkov, Y. N., Boytsov, S. A., Bubnova, M. G., et al. (2024) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2024-6162 · Cited by 204
van Rein, N., Heide-Jørgensen, U., Lijfering, W. M., Dekkers, O. M., Sørensen, H. T., & Cannegieter, S. C. (2019) · Circulation · doi:10.1161/circulationaha.118.036248 · Cited by 204
Eikelboom, J., Berger, P., Holmes, D., Bhatt, D., Becker, R., Angiolill, D., Faxon, D., & Moliterno, D. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-04-0262 · Cited by 204
OLESEN, J. B., LIP, G. Y. H., HANSEN, P. R., LINDHARDSEN, J., AHLEHOFF, O., ANDERSSON, C., WEEKE, P., HANSEN, M. L., GISLASON, G. H., & TORP‐PEDERSEN, C. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04378.x · Cited by 201
Self-citationKosiuk, J., Dinov, B., Kornej, J., Acou, W.-J., Schönbauer, R., Fiedler, L., Buchta, P., Myrda, K., Gąsior, M., Poloński, L., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.07.003 · Cited by 199
Medical Services Advisory Committee
Culyer, A. J. (2014) · Cited by 199
Turakhia, M. P., Ziegler, P. D., Schmitt, S. K., Chang, Y., Fan, J., Than, C. T., Keung, E. K., & Singer, D. E. (2015) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.114.003057 · Cited by 197
Diretriz Brasileira de Valvopatias - SBC 2011/ I Diretriz Interamericana de Valvopatias - SIAC 2011
Tarasoutchi, F., Montera, M., Grinberg, M., Barbosa, M., Piñeiro, D., Sánchez, C., & Barbosa, M. (2011) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2011002000001 · Cited by 197
Sticherling, C., Marin, F., Birnie, D., Boriani, G., Calkins, H., Dan, G.-A., Gulizia, M., Halvorsen, S., Hindricks, G., Kuck, K.-H., et al. (2015) · EP Europace · doi:10.1093/europace/euv190 · Cited by 197
Self-citationSevere Renal Impairment and Stroke Prevention in Atrial Fibrillation
Marinigh, R., Lane, D. A., & Lip, G. Y. H. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.12.013 · Cited by 195
Self-citationMorin, D. P., Bernard, M. L., Madias, C., Rogers, P. A., Thihalolipavan, S., & Estes, N. A. M. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.08.022 · Cited by 194
Padfield, G. J., Steinberg, C., Swampillai, J., Qian, H., Connolly, S. J., Dorian, P., Green, M. S., Humphries, K. H., Klein, G. J., Sheldon, R., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.01.038 · Cited by 194
Aminizadeh, S., Heidari, A., Toumaj, S., Darbandi, M., Navimipour, N. J., Rezaei, M., Talebi, S., Azad, P., & Unal, M. (2023) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2023.107745 · Cited by 193
Rate control in atrial fibrillation
Van Gelder, I. C., Rienstra, M., Crijns, H. J. G. M., & Olshansky, B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31258-2 · Cited by 193
Self-citationA Simple Clinical Risk Score (C2HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects
Li, Y.-G., Pastori, D., Farcomeni, A., Yang, P.-S., Jang, E., Joung, B., Wang, Y.-T., Guo, Y.-T., & Lip, G. Y. H. (2019) · Chest · doi:10.1016/j.chest.2018.09.011 · Cited by 193
Self-citation2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
Chiang, C., Okumura, K., Zhang, S., Chao, T., Siu, C., Wei Lim, T., Saxena, A., Takahashi, Y., & Siong Teo, W. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.05.004 · Cited by 192
Landmesser, U., Schmidt, B., Nielsen‐Kudsk, J. E., Lam, S. C. C., Park, J., Tarantini, G., Cruz‐González, I., Geist, V., Bella, P. E. D., Colombo, A., et al. (2017) · EuroIntervention · doi:10.4244/eij-d-17-00493 · Cited by 192
Roldán, V., Marín, F., Manzano-Fernández, S., Gallego, P., Vílchez, J. A., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.1623 · Cited by 190
Self-citationKelly, D., Ademi, Z., Doehner, W., Lip, G. Y. H., Mark, P. B., Toyoda, Ḱ., Wong, C. X. J., Sarnak, M. J., Cheung, M., Herzog, C. A., et al. (2021) · Stroke · doi:10.1161/strokeaha.120.029680 · Cited by 192
Self-citationRelationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation
Chao, T.-F., Lip, G. Y. H., Liu, C.-J., Lin, Y.-J., Chang, S.-L., Lo, L.-W., Hu, Y.-F., Tuan, T.-C., Liao, J.-N., Chung, F.-P., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.085 · Cited by 188
Self-citationCHADS 2 , CHA 2 DS 2 -VASc, and long-term stroke outcome in patients without atrial fibrillation
Ntaios, G., Lip, G. Y. H., Makaritsis, K., Papavasileiou, V., Vemmou, A., Koroboki, E., Savvari, P., Manios, E., Milionis, H., & Vemmos, K. (2013) · Neurology · doi:10.1212/wnl.0b013e318287281b · Cited by 188
Self-citationChen, L. Y., Ribeiro, A. L. P., Platonov, P. G., Cygankiewicz, I., Soliman, E. Z., Görenek, B., Ikeda, T., Vassilikos, V. P., Steinberg, J. S., Varma, N., et al. (2022) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.121.010435 · Cited by 188
Di Carlo, A., Bellino, L., Consoli, D., Mori, F., Zaninelli, A., Baldereschi, M., Cattarinussi, A., D’Alfonso, M. G., Gradia, C., Sgherzi, B., et al. (2019) · EP Europace · doi:10.1093/europace/euz141 · Cited by 187
Lee, E., Choi, E.-K., Han, K.-D., Lee, H., Choe, W.-S., Lee, S.-R., Cha, M.-J., Lim, W.-H., Kim, Y.-J., & Oh, S. (2018) · PLOS ONE · doi:10.1371/journal.pone.0209687 · Cited by 187
Improving Stroke Risk Stratification in Atrial Fibrillation
Lip, G. Y. H., & Halperin, J. L. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.12.013 · Cited by 185
Self-citationCoppens, M., Eikelboom, J. W., Hart, R. G., Yusuf, S., Lip, G. Y. H., Dorian, P., Shestakovska, O., & Connolly, S. J. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs314 · Cited by 184
“Furthermore, in some of the previous validation cohorts, patients were receiving anticoagulant therapy with a VKA.(7,8) This is problematic because risk discrimination in patients already receiving a VKA is not relevant to the decision whether or not to treat with a VKA.”
BackgroundResultInfluentialSelf-citationHunter, R. J., McCready, J., Diab, I., Page, S. P., Finlay, M., Richmond, L., French, A., Earley, M. J., Sporton, S., Jones, M., et al. (2012) · Heart · doi:10.1136/heartjnl-2011-300720 · Cited by 183
Quinn, T. J., Richard, E., Teuschl, Y., Gattringer, T., Hafdi, M., O'Brien, J. T., Merriman, N., Gillebert, C., Huygelier, H., Verdelho, A., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.15068 · Cited by 182
2023 HRS expert consensus statement on the management of arrhythmias during pregnancy
Joglar, J. A., Kapa, S., Saarel, E. V., Dubin, A. M., Görenek, B., Hameed, A. B., de Melo, S. L., Leal, M. A., Mondesert, B. A., Pacheco, L. D., et al. (2023) · Heart Rhythm · doi:10.1016/j.hrthm.2023.05.017 · Cited by 184
Atrial fibrillation and stroke: State-of-the-art and future directions
Elsheikh, S., Hill, A. M., Irving, G. J., Lip, G. Y. H., & Abdul‐Rahim, A. H. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102181 · Cited by 182
Self-citationCare Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes
Echouffo-Tcheugui, J. B., Shrader, P., Thomas, L., Gersh, B. J., Kowey, P. R., Mahaffey, K. W., Singer, D. E., Hylek, E. M., Go, A. S., Peterson, E. D., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.755 · Cited by 180
Kent, D. M., van Klaveren, D., Paulus, J. K., D'Agostino, R., Goodman, S., Hayward, R., Ioannidis, J. P. A., Patrick-Lake, B., Morton, S., Pencina, M., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m18-3668 · Cited by 179
Implications of the CHA2DS2-VASc and HAS-BLED Scores for Thromboprophylaxis in Atrial Fibrillation
Lip, G. Y. H. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.05.007 · Cited by 181
Self-citationSiontis, K. C., Gersh, B. J., Killian, J. M., Noseworthy, P. A., McCabe, P., Weston, S. A., Roger, V. L., & Chamberlain, A. M. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.03.003 · Cited by 178
Embolic Strokes of Undetermined Source in the Athens Stroke Registry: A Descriptive Analysis
Ntaios, G., Papavasileiou, V., Milionis, H., Makaritsis, K., Manios, E., Spengos, K., Michel, P., & Vemmos, K. (2015) · Stroke · doi:10.1161/strokeaha.114.007240 · Cited by 178
Fox, K. A. A., Lucas, J. E., Pieper, K. S., Bassand, J.-P., Camm, A. J., Fitzmaurice, D. A., Goldhaber, S. Z., Goto, S., Haas, S., Hacke, W., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017157 · Cited by 150
Diabetes mellitus and stroke: A clinical update
Tun, N. N., Arunagirinathan, G., Munshi, S. K., & Pappachan, J. M. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i6.235 · Cited by 177
Secondary stroke prevention: challenges and solutions
Gutierrez, J., & Esenwa, C. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s63791 · Cited by 177
Benesch, C., Glance, L. G., Derdeyn, C. P., Fleisher, L. A., Holloway, R. G., Messé, S. R., Mijalski, C., Nelson, M. T., Power, M., Welch, B. G., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000968 · Cited by 177
The future of atrial fibrillation management: integrated care and stratified therapy
Kirchhof, P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31072-3 · Cited by 177
Atrial Cardiopathy: A Broadened Concept of Left Atrial Thromboembolism Beyond Atrial Fibrillation
Kamel, H., Okin, P. M., Longstreth, W., Elkind, M. S., & Soliman, E. Z. (2015) · Future Cardiology · doi:10.2217/fca.15.22 · Cited by 177
Thompson, L. E., Maddox, T. M., Lei, L., Grunwald, G. K., Bradley, S. M., Peterson, P. N., Masoudi, F. A., Turchin, A., Song, Y., Doros, G., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005801 · Cited by 153
Wagstaff, A. J., Overvad, T. F., Lip, G. Y. H., & Lane, D. A. (2014) · QJM · doi:10.1093/qjmed/hcu054 · Cited by 176
“6 More recent evidence has suggested that other previously ‘less-well’ validated risk factors, such as vascular disease, age 65–74 years and female gender may also be associated with increased stroke risk among AF patients.(2,5,7) These newer ‘nonCHADS2’ risk factors are incorporated in the CHA2DS2-VASc score, 7 which…”
BackgroundSelf-citationAtrial fibrillation and stroke: A review and new insights
Escudero-Martínez, I., Morales-Caba, L., & Segura, T. (2023) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2021.12.001 · Cited by 176
Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation
Schnabel, R. B., Pecen, L., Ojeda, F. M., Lucerna, M., Rzayeva, N., Blankenberg, S., Darius, H., Kotecha, D., Caterina, R. D., & Kirchhof, P. (2017) · Heart · doi:10.1136/heartjnl-2016-310406 · Cited by 176
Chao, T.-F., Liu, C.-J., Wang, K.-L., Lin, Y.-J., Chang, S.-L., Lo, L.-W., Hu, Y.-F., Tuan, T.-C., Chen, T.-J., Lip, G. Y. H., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1203 · Cited by 176
Self-citationObokata, M., Negishi, K., Kurosawa, K., Tateno, R., Tange, S., Arai, M., Amano, M., & Kurabayashi, M. (2014) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.03.010 · Cited by 176
Assessment of Left Atrial Fibrosis by Late Gadolinium Enhancement Magnetic Resonance Imaging
Siebermair, J., Kholmovski, E. G., & MARROUCHE, N. F. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.07.004 · Cited by 174
Shah, S., Norby, F. L., Datta, Y. H., Lutsey, P. L., MacLehose, R. F., Chen, L. Y., & Alonso, A. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017010694 · Cited by 173
Swiryn, S., Orlov, M. V., Benditt, D. G., DiMarco, J. P., Lloyd-Jones, D. M., Karst, E., Qu, F., Slawsky, M. T., Turkel, M., & Waldo, A. L. (2016) · Circulation · doi:10.1161/circulationaha.115.020252 · Cited by 154
Stroke and thromboembolism prevention in atrial fibrillation
Jamé, S., & Barnes, G. D. (2019) · Heart · doi:10.1136/heartjnl-2019-314898 · Cited by 174
O'Brien, E. C., Holmes, D. N., Ansell, J. E., Allen, L. A., Hylek, E., Kowey, P. R., Gersh, B. J., Fonarow, G. C., Koller, C. R., Ezekowitz, M. D., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2013.12.014 · Cited by 171
Yiin, G. S. C., Howard, D. P. J., Paul, N. L. M., Li, L., Luengo-Fernandez, R., Bull, L. M., Welch, S. J. V., Gutnikov, S. A., Mehta, Z., & Rothwell, P. M. (2014) · Circulation · doi:10.1161/circulationaha.114.010942 · Cited by 170
Hatta, W., Tsuji, Y., Yoshio, T., Kakushima, N., Hoteya, S., Doyama, H., Nagami, Y., Hikichi, T., Kobayashi, M., Morita, Y., et al. (2021) · Gut · doi:10.1136/gutjnl-2019-319926 · Cited by 170
Hijazi, Z., Wallentin, L. C., Siegbahn, A., Andersson, U., Alexander, J. H., Atar, D., Gersh, B. J., Hanna, M., Harjola, V., Horowitz, J. D., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.093 · Cited by 174
Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?
Lip, G. Y. H. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs435 · Cited by 157
Self-citationMiller, J. D., Aronis, K. N., Chrispin, J., Patil, K. D., Marine, J. E., Martin, S. S., Blaha, M. J., Blumenthal, R. S., & Calkins, H. G. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.047 · Cited by 171
Neri, L., Oberdier, M. T., van Abeelen, K. C. J., Menghini, L., Tumarkin, E., Tripathi, H., Jaipalli, S., Orro, A., Paolocci, N., Gallelli, I., et al. (2023) · Sensors · doi:10.3390/s23104805 · Cited by 132
Epidemiology of Atrial Fibrillation
Zhang, J., Johnsen, S. P., Guo, Y., & Lip, G. Y. H. (2021) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2020.10.010 · Cited by 168
Self-citationLampert, R., Chung, E. H., Ackerman, M. J., Arroyo, A. R., Darden, D., Deo, R., Dolan, J., Etheridge, S. P., Gray, B. R., Harmon, K. G., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.05.018 · Cited by 167
Cresti, A., García-Fernández, M. A., Sievert, H., Mazzone, P., Baratta, P., Solari, M., Geyer, A., De Sensi, F., & Limbruno, U. (2019) · EuroIntervention · doi:10.4244/eij-d-19-00128 · Cited by 167
Quinn, T. J., Richard, E., Teuschl, Y., Gattringer, T., Hafdi, M., O'Brien, J. T., Merriman, N. A., Gillebert, C. R., Huygelier, H., Verdelho, A., et al. (2021) · European Stroke Journal · doi:10.1177/23969873211042192 · Cited by 169
Boriani, G., Proietti, M., Laroche, C., Fauchier, L., Marin, F., Nabauer, M., Potpara, T., Dan, G.-A., Kalarus, Z., Diemberger, I., et al. (2018) · EP Europace · doi:10.1093/europace/eux301 · Cited by 165
Self-citationLee, S.-R., Choi, E.-K., Han, K.-D., Cha, M.-J., & Oh, S. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.02.039 · Cited by 165
Coyle, D., Coyle, K., Cameron, C. G., Lee, K. S., Kelly, S., Steiner, S., & Wells, G. A. (2013) · Value in Health · doi:10.1016/j.jval.2013.01.009 · Cited by 166
‘Real-World’ Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey
Lip, G. Y. H., Laroche, C., Dan, G., Santini, M., Kalarus, Z. F., Rasmussen, L. H., Ioachim, P. M., Țica, O., Boriani, G., Cimaglia, P., et al. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.12.022 · Cited by 164
Self-citationHippisley-Cox, J., Coupland, C., & Brindle, P. (2013) · BMJ · doi:10.1136/bmj.f2573 · Cited by 153
Fanola, C. L., Ruff, C. T., Murphy, S. A., Jin, J., Duggal, A., Babilonia, N. A., Sritara, P., Mercuri, M. F., Kamphuisen, P. W., Antman, E. M., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008987 · Cited by 165
Görenek, B., Lundqvist, C. B., Brugada, J., Camm, A. J., Hindricks, G., Huber, K., Kirchhof, P. F., Kück, K., Kudaiberdieva, G., Lin, T., et al. (2014) · EP Europace · doi:10.1093/europace/euu208 · Cited by 165
Self-citationPrediction of Thrombo-Embolic Risk in Patients with Hypertrophic Cardiomyopathy (HCM Risk-CVA)
Guttmann, O. P., Pavlou, M., O’Mahony, C., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., Garcia-Pavia, P., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.316 · Cited by 163
Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H., Dubner, S., Halperin, J. L., Ma, C., Zint, K., Elsaesser, A., et al. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.07.013 · Cited by 165
Self-citationTamayo, S. G., Peacock, W. F., Patel, M. R., Sicignano, N., Hopf, K. P., Fields, L. E., Sarich, T. C., Wu, S., Yannicelli, D., & Yuan, Ž. (2015) · Clinical Cardiology · doi:10.1002/clc.22373 · Cited by 164
Transcarotid Transcatheter Aortic Valve Replacement
Mylotte, D., Sudre, A., Teíger, E., Obadia, J. F., Lee, M., Spence, M., Khamis, H., Nooryani, A. A. A., Delhaye, C., Amr, G., et al. (2016) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2015.11.045 · Cited by 163
The Global Burden of Atrial Fibrillation and Stroke
Bai, Y., Wang, Y., Shantsila, A., & Lip, G. Y. H. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.03.048 · Cited by 164
Self-citationDijkland, S. A., Foks, K. A., Polinder, S., Dippel, D. W. J., Maas, A. I. R., Lingsma, H. F., & Steyerberg, E. W. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2019.6401 · Cited by 162
Chao, T.-F., Lin, Y.-J., Tsao, H.-M., Tsai, C.-F., Lin, W.-S., Chang, S.-L., Lo, L.-W., Hu, Y.-F., Tuan, T.-C., Suenari, K., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.045 · Cited by 162
Lip, G. Y. H., Wang, K.-L., & Chiang, C.-E. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.11.182 · Cited by 162
Self-citationSchnabel, R. B., Wilde, S., Wild, P. S., Münzel, T. F., & Blankenberg, S. (2012) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2012.0293 · Cited by 164
Kirchhof, P., Breithardt, G., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., Boriani, G., Brandes, A., Brown, H., Brueckmann, M., Calkins, H., et al. (2016) · Europace · doi:10.1093/europace/euv304 · Cited by 141
Self-citationGalea, R., MARCO, F. D., Meneveau, N. F., Aminian, A., Anselme, F., Gräni, C., Huber, A. T., Teíger, E., Iriart, X., Bosombo, F. B., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.057859 · Cited by 162
Martin, R. I. R., Pogoryelova, O., Koref, M. S., Bourke, J. P., Teare, M. D., & Keavney, B. D. (2014) · Heart · doi:10.1136/heartjnl-2014-305482 · Cited by 161
Friberg, L., Benson, L., & Lip, G. Y. H. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu139 · Cited by 161
Self-citationMitchell, L. B., Southern, D. A., Galbraith, D., Ghali, W. A., Knudtson, M., & Wilton, S. B. (2014) · Heart · doi:10.1136/heartjnl-2013-305303 · Cited by 161
Lip, G. Y. H., Clémenty, N., Pericart, L., Banerjee, A., & Fauchier, L. (2014) · Stroke · doi:10.1161/strokeaha.114.007199 · Cited by 162
Self-citationCarrero, J. J., Evans, M., Szummer, K., Spaak, J., Lindhagen, L., Edfors, R., Stenvinkel, P., Jacobson, S. H., & Jernberg, T. (2014) · JAMA · doi:10.1001/jama.2014.1334 · Cited by 160
Cowan, C., Healicon, R., Robson, I., Long, W. R., Barrett, J., Fay, M., Tyndall, K., & Gale, C. P. (2013) · Heart · doi:10.1136/heartjnl-2012-303472 · Cited by 163
How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemia
Stephens, D. M., & Byrd, J. C. (2019) · Blood · doi:10.1182/blood-2018-11-846808 · Cited by 160
Pisters, R., Lane, D. A., Marin, F., Camm, A. J., & Lip, G. Y. H. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-1036 · Cited by 159
Self-citationA 12-Year Follow-up Study of Patients With Newly Diagnosed Lone Atrial Fibrillation
Potpara, T. S., Stankovic, G. R., Beleslin, B. D., Polovina, M. M., Marinkovic, J. M., Ostojic, M. C., & Lip, G. Y. H. (2012) · Chest · doi:10.1378/chest.11-0340 · Cited by 159
Self-citationO'Mahony, C., Tome-Esteban, M., Lambiase, P. D., Pantazis, A., Dickie, S., McKenna, W. J., & Elliott, P. M. (2013) · Heart · doi:10.1136/heartjnl-2012-303271 · Cited by 159
Saliba, W., Gronich, N., Barnett‐Griness, O., & Rennert, G. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.02.029 · Cited by 160
Steinberg, B. A., Kim, S., Piccini, J. P., Fonarow, G. C., Lópes, R. D., Thomas, L. E., Ezekowitz, M. D., Ansell, J., Kowey, P. R., Singer, D. E., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002927 · Cited by 159
Mashour, G. A., Moore, L. E., Lele, A. V., Robicsek, S. A., & Gelb, A. W. (2014) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0000000000000087 · Cited by 158
II Diretrizes Brasileiras de Fibrilação Atrial
Magalhães, L., Figueiredo, M., Cintra, F., Eb, S., Kuniyoshi, R. R., Teixeira, R., Filho, A. L., d’Ávila, A., de Paola, A., Kalil, C., et al. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160055 · Cited by 160
Melduni, R. M., Schaff, H. V., Lee, H.-C., Gersh, B. J., Noseworthy, P. A., Bailey, K. R., Ammash, N. M., Cha, S. S., Fatema, K., Wysokinski, W. E., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.021952 · Cited by 150
Management of Atrial Fibrillation in Patients With Structural Heart Disease
Darby, A. E., & Dimarco, J. (2012) · Circulation · doi:10.1161/circulationaha.111.019935 · Cited by 157
Cowan, J. C., Wu, J., Hall, M., Orlowski, A., West, R. M., & Gale, C. P. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy411 · Cited by 159
DeepHeart: Semi-Supervised Sequence Learning for Cardiovascular Risk Prediction
Ballinger, B., Hsieh, J., Singh, A., Sohoni, N., Wang, J., Tison, G., Marcus, G., Sanchez, J., Maguire, C., Olgin, J., et al. (2018) · Proceedings of the AAAI Conference on Artificial Intelligence · doi:10.1609/aaai.v32i1.11891 · Cited by 156
Essien, U. R., Holmes, D. N., Jackson, L. R., Fonarow, G. C., Mahaffey, K. W., Reiffel, J. A., Steinberg, B. A., Allen, L. A., Chan, P. S., Freeman, J. V., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.3945 · Cited by 155
Aulin, J., Siegbahn, A. G., Hijazi, Z., Ezekowitz, M. D., Andersson, U., Connolly, S. J., Huber, K., Reilly, P. A., Wallentin, L. C., & Oldgren, J. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.09.018 · Cited by 155
Metadata
- Authors
- Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M.
- Affiliations
- Birmingham City Hospital (GB)
- Maastricht University Medical Centre (NL)
- Corresponding author
- Lip, Gregory Y.H.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 137
- Issue
- 2
- Pages
- 263-272
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2162586165
- Cited by
- 6,879
- References
- 34
- Citations by year
- 2026: 276 · 2025: 362 · 2024: 419 · 2023: 466 · 2022: 524 · 2021: 590 · 2020: 538 · 2019: 476 · 2018: 507 · 2017: 471 · 2016: 495 · 2015: 474 · 2014: 400 · 2013: 337 · 2012: 304
- FWCI
- 115.14
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- atrial fibrillation, stroke risk stratification, thromboembolism, CHA2DS2-VASc score, CHADS2 score, risk prediction, risk reclassification
- MeSH terms
- Aged, Atrial Fibrillation, Europe, Female, Follow-Up Studies, Humans, Male, Population Surveillance, Prognosis, Retrospective Studies, Risk Factors, Thromboembolism, Reproducibility of Results, Incidence, Risk Assessment, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.